Aebi Schmidt vs Hyster-Yale
AEBI and HY side by side, both in construction, mining, and materials handling. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AEBI and HY compare
Aebi Schmidt is the larger company, worth 1.6 times as much as Hyster-Yale ($804M against $488M).
Aebi Schmidt grew revenue faster over the last twelve months (52.2% versus −14.2% for Hyster-Yale).
Aebi Schmidt keeps more of each dollar of sales as profit, with a net margin of 1.6% compared with −3.9% at Hyster-Yale.
Both pay dividends: Aebi Schmidt yields 1.2% and Hyster-Yale 5.3%.
Aebi Schmidt scores higher on the StockData Score (9 against 7 for Hyster-Yale), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AEBI | HY |
|---|---|---|
| Size and price | ||
| Market cap | $804M | $488M |
| Share price | $10.36 | $27.22 |
| Change, 1 year | −3.4% | −8.6% |
| Change, 5 years | – | −33.9% |
| Beta (5Y) | 1.38 | 1.13 |
| Employees | 5,700 | 7,500 |
| StockData Score | ||
| Total score | 9 (better) | 7 |
| Valuation score | 4 (better) | 2 |
| Growth score | 1 (better) | 0 |
| Performance score | 0 | 0 |
| Health score | 1 | 1 |
| Dividend score | 3 | 4 (better) |
| Valuation | ||
| P/E | 25.9× | – |
| P/S | 0.4× | 0.1× (better) |
| P/B | 1.0× (better) | 1.3× |
| EV/EBITDA | 8.7× | – |
| P/FCF | 40.4× (better) | 104× |
| FCF yield | 2.5% (better) | 0.96% |
| Fair value | $13.36 | $60.32 |
| Margin of safety | 22.5% | 54.9% (better) |
| Growth | ||
| Revenue growth (TTM) | 52.2% (better) | −14.2% |
| Revenue growth, 5Y average | – | 6.0% |
| Net income growth (TTM) | 195% (better) | −4896% |
| EPS growth (TTM) | 66.7% (better) | −5286% |
| Profitability | ||
| Gross margin | 19.2% (better) | 15.1% |
| Operating margin | 4.7% (better) | −2.8% |
| Net margin | 1.6% (better) | −3.9% |
| FCF margin | 1.0% (better) | 0.14% |
| Return on equity | 3.7% (better) | −28.6% |
| Return on invested capital | 4.8% (better) | −9.4% |
| Financial health | ||
| Debt / equity | 0.70 (better) | 1.06 |
| Net debt / EBITDA | 3.34 | – |
| Interest coverage | 2.1× (better) | −3.1× |
| Current ratio | 2.08 (better) | 1.24 |
| Altman Z-score | 1.89 | 2.06 (better) |
| Piotroski F-score | 4 (better) | 3 |
| Dividends and buybacks | ||
| Dividend yield | 1.2% | 5.3% (better) |
| Payout ratio | 25.1% | – |
| Years of dividend growth | 2 | 12 (better) |
| Dividend growth, 5Y average | – | 2.4% |
| Buyback yield | – | −1.7% |
| Shareholder yield | 1.2% | 3.6% (better) |
| Ownership | ||
| Held by institutions | – | 48.6% |
| Held by insiders | 66.6% | 48.4% |
| Insider net buying, 12 months | $349K | – |
| Short interest, % of float | 6.5% | 7.1% |
Go deeper
- AEBI stock overview
- AEBI income statement
- AEBI valuation and score
- HY stock overview
- HY income statement
- HY valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.